Discontinue use & institute appropriate treatment if irritation, sensitivity or other reaction develops. May produce systemic effects (eg, hypothalamic-pituitary-adrenal axis suppression, Cushing's syndrome manifestation, hyperglycaemia & glucosuria. Do not use in or around the eyes. Blurred vision or other visual disturbances. Prolonged treatment when treating extensive BSA when using occlusive technique & when treating childn. Pregnancy & lactation.
Exemptions granted for limited sale and supply without prescription (with effect from 31 March 2016):
As a topical preparation (as valerate or dipropionate salt) as a single agent not exceeding 0.1%
Indication: Symptomatic relief of inflammatory skin or scalp disorders such as dermatitis and eczema
Maximum daily dose: Apply to affected areas twice daily
Maximum supply: 15 g for cream/ointment/gel; 30 mL for topical solution
Minimum age: 18 years
Presentation/Packing
Form
Beprosone cream 0.064% w/w
Packing/Price
15 g x 1's
Form
Beprosone oint 0.064 % w/w
Packing/Price
15 g x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign Out
